echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Neurosurgery Professor Zhou Liangxue’s team published a research paper in Molecular Cancer to fully analyze the characteristics of craniopharyngioma gene mutations

    Neurosurgery Professor Zhou Liangxue’s team published a research paper in Molecular Cancer to fully analyze the characteristics of craniopharyngioma gene mutations

    • Last Update: 2022-01-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, the team of Professor Liangxue Zhou of Neurosurgery of our hospital cooperated with the team of Professor Yong Peng from the State Key Laboratory of Biological Therapy and the team of Professor Xiaofeng Zhu from the School of Life Sciences of Sichuan University.
    They published an online publication titled "Characterization of novel CTNNB1 mutation" in the famous journal Molecular Cancer (IF=27.
    4).
    in Craniopharyngioma by whole-genome sequencing" research paper
    .


    The study performed whole-genome sequencing analysis on 26 cases of craniopharyngiomas (including 16 cases of enamel craniopharyngiomas and 10 cases of squamous papillary craniopharyngiomas) and their corresponding blood samples.


    Craniopharyngioma is a rare benign tumor that tends to occur in the intracranial saddle area and supra saddle
    .


    Although it is a benign tumor histologically, the clinical disease process often shows progressive deterioration, and it is still considered as a refractory intracranial tumor


    The study performed whole-genome sequencing on 26 pairs of craniopharyngiomas samples, with an average sequencing depth of 29.
    51× (tumor) and 29.
    75× (blood).
    A total of 20,772 individual cell mutations were detected.
    The median of SNV and InDels was 760, respectively.
    And 39, the average mutation load of SNV and InDels were 0.
    246 bp/M and 0.
    013 bp/M, respectively, which accorded with the gene mutation characteristics of benign tumors
    .


    The study found that CTNNB1 (68.


    Doctoral students He Juan, Zeng Zhen, and assistant researcher Wang Yuelong are the co-first authors of the article.
    Professor Zhou Liangxue of Neurosurgery, West China Hospital of Sichuan University, Professor Peng Yong of West China Biotherapy State Key Laboratory of Sichuan University, and Professor Zhu Xiaofeng of the School of Life Sciences of Sichuan University are the joint communications Author
    .



    Original link: https://molecular-cancer.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.